Jennifer Kaivers - Concepedia

Author

Jennifer Kaivers

Heinrich Heine University Düsseldorf ORCID

Also Known As

J. Kaivers, Jennifer Kaivers, Kaivers Jennifer

Publications

549

Citations

H-Index

Concepts

All Affiliations

Heinrich Heine University Düsseldorf Düsseldorf University Hospital Ludwig-Maximilians-Universität München Heidelberg University University Hospital Heidelberg

About

Jennifer Kaivers is an author at Heinrich Heine University Düsseldorf specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	190
2	Public Health	1	1	10
3	Cellular Therapies	1	1	31
4	Emergency Medicine	1	1	97
5	Health Policy	1	1	10

Jennifer Kaivers

Publications

466

Citations

H-Index

Page 1

	Year	Citations
Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents Sophie Park, Jean-François Hamel, Andréa Toma, Journal of Clinical Oncology Hematological MalignancyErythropoiesis-stimulating AgentsOncologyBone Marrow FailureLower-risk Patients	2017	97
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group Esther Schuler, Eva‐Maria Wagner‐Drouet, Salem Ajib, Annals of Hematology	2020	65
EASIX for prediction of survival in lower-risk myelodysplastic syndromes Almuth Maria Anni Merz, Ulrich Germing, Guido Kobbe, Blood Cancer Journal	2019	59
Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study Lisa Pleyer, Michael Leisch, Alexandra Kourakli, The Lancet Haematology Hematological MalignancyNon-curative TherapiesRetrospective Cohort StudyMedicineMixed-phenotype Acute Leukemia	2021	52
Prediction of Response and Survival Following Treatment with Azacitidine for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation Christina Rautenberg, Anika Bergmann, Ulrich Germing, Cancers	2020	47
Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients Tobias Silzle, Sabine Blum, Esther Schuler, Blood Cancer Journal	2019	32
Daratumumab for treatment of pure red cell aplasia after allogeneic stem cell transplantation Christina Rautenberg, Jennifer Kaivers, Ulrich Germing, Bone Marrow Transplantation Cell TherapyTransplantationMarrow TransplantationCell AplasiaStem Cell Transplantation	2019	31
Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosis Judith Neukirchen, Michael Lauseker, Barbara Hildebrandt, Cancer	2017	23
Prognostic impact of pretransplant measurable residual disease assessed by peripheral blood <i>WT1</i>‐mRNA expression in patients with AML and MDS Christina Rautenberg, Michael Lauseker, Jennifer Kaivers, European Journal Of Haematology	2021	23
Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries Johannes Lübke, Deborah Christen, Juliana Schwaab, Leukemia	2024	16

Page 1